» Articles » PMID: 36969884

Role of Noncoding RNAs in the Tumor Immune Microenvironment of Hepatocellular Carcinoma

Overview
Specialty Gastroenterology
Date 2023 Mar 27
PMID 36969884
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies. It has high mortality and poor clinical outcomes, but the molecular mechanisms in the pathogenesis of HCC are not understood. The tumor immune microenvironment (TIME) is a highly intricate system with distinct populations of innate and adaptive immune cells, as well as other stromal cells. They interact and evolve with tumor cells to influence tumor growth, migration, invasion, immune evasion, and response to therapy. Emerging evidence has shown noncoding RNAs (ncRNAs) are prominent regulators of TIME in HCC. In this review, we elaborate on the functions and molecular mechanisms of ncRNAs in remodeling TIME of HCC and discuss their diagnostic and therapeutic potential for HCC treatment.

Citing Articles

Identification and Validation of the Hsa_circ_0001726/miR-140-3p/KRAS Axis in Hepatocellular Carcinoma Based on Microarray Analyses and Experiments.

Chi X, Chen Z, Yu J, Xie X, Lin Z, Chen Y J Clin Transl Hepatol. 2024; 12(11):897-906.

PMID: 39544243 PMC: 11557365. DOI: 10.14218/JCTH.2024.00270.


Treatment Options for Hepatocellular Carcinoma Using Immunotherapy: Present and Future.

Wei H, Dong C, Li X J Clin Transl Hepatol. 2024; 12(4):389-405.

PMID: 38638377 PMC: 11022065. DOI: 10.14218/JCTH.2023.00462.


Immune Regulatory Networks and Therapy of γδ T Cells in Liver Cancer: Recent Trends and Advancements.

Yin K, Chu K, Li M, Duan Y, Yu Y, Kang M J Clin Transl Hepatol. 2024; 12(3):287-297.

PMID: 38426194 PMC: 10899867. DOI: 10.14218/JCTH.2023.00355.


IGF2BP3 Enhances the Growth of Hepatocellular Carcinoma Tumors by Regulating the Properties of Macrophages and CD8 T Cells in the Tumor Microenvironment.

Ma L, Jiang J, Si Q, Chen C, Duan Z J Clin Transl Hepatol. 2023; 11(6):1308-1320.

PMID: 37719968 PMC: 10500288. DOI: 10.14218/JCTH.2023.00184.

References
1.
Tanaka A, Sakaguchi S . Regulatory T cells in cancer immunotherapy. Cell Res. 2016; 27(1):109-118. PMC: 5223231. DOI: 10.1038/cr.2016.151. View

2.
Hsu S, Wang B, Kota J, Yu J, Costinean S, Kutay H . Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J Clin Invest. 2012; 122(8):2871-83. PMC: 3408748. DOI: 10.1172/JCI63539. View

3.
Hu Z, Zhou S, Li J, Zhou Z, Wang P, Xin H . Circular RNA Sequencing Identifies CircASAP1 as a Key Regulator in Hepatocellular Carcinoma Metastasis. Hepatology. 2019; 72(3):906-922. DOI: 10.1002/hep.31068. View

4.
Franklin R, Liao W, Sarkar A, Kim M, Bivona M, Liu K . The cellular and molecular origin of tumor-associated macrophages. Science. 2014; 344(6186):921-5. PMC: 4204732. DOI: 10.1126/science.1252510. View

5.
Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu M, Allen C . The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015. JAMA Oncol. 2017; 3(12):1683-1691. PMC: 5824275. DOI: 10.1001/jamaoncol.2017.3055. View